Fighting MRSA resistance
As reported (here) previously, Israel’s Biomica is developing microbiome therapies for antibiotic resistant bacteria. It is now partnering with the Weizmann Institute to develop a selective treatment against MRSA – antibiotic resistant strains of Staphylococcus aureus infection.
This entry was posted in Israel's Medical Achievements
. Bookmark the permalink